Laboratorio Reig Jofre, S.A. (BME:RJF)

Spain flag Spain · Delayed Price · Currency is EUR
2.930
-0.030 (-1.01%)
Oct 28, 2025, 1:43 PM CET
-1.01%
Market Cap240.92M
Revenue (ttm)336.87M
Net Income (ttm)6.38M
Shares Out81.39M
EPS (ttm)0.08
PE Ratio37.48
Forward PE16.44
Dividend0.05 (1.66%)
Ex-Dividend DateMay 15, 2025
Volume67,978
Average Volume58,595
Open2.950
Previous Close2.960
Day's Range2.910 - 3.000
52-Week Range2.460 - 3.400
Beta0.76
RSI44.66
Earnings DateNov 5, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und... [Read more]

Sector Healthcare
Founded 1929
Employees 1,437
Stock Exchange Madrid Stock Exchange
Ticker Symbol RJF
Full Company Profile

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.

Financial Statements

News

There is no news available yet.